Wayne Sawlivich

Title: Wayne Sawlivich: Innovator in Biopharmaceuticals

Introduction

Wayne Sawlivich is a notable inventor based in Wilmington, MA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative methods for producing therapeutic conjugates. With a total of 3 patents to his name, Sawlivich's work has the potential to impact the treatment of various diseases.

Latest Patents

Sawlivich's latest patents include a method for producing polyol-IFN-β conjugates, specifically PEG-IFN-β conjugates. This process involves the site-specific PEGylation of human IFN-β using a thiol-reactive PEGylating agent. The resulting pharmaceutical composition aims to treat infections, tumors, and autoimmune and inflammatory diseases. Additionally, his inventions relate to a method for the stepwise attachment of PEG moieties in series to a polypeptide, particularly focusing on IFN-β.

Career Highlights

Throughout his career, Wayne Sawlivich has worked with prominent companies in the biopharmaceutical sector, including Merck Serono S.A. and Laboratoires Serono S.A. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Sawlivich has collaborated with notable professionals in his field, including Nabil El-Tayar and Michael James Roberts. These collaborations have likely enhanced his research and development efforts, leading to significant advancements in his patented technologies.

Conclusion

Wayne Sawlivich is a distinguished inventor whose work in biopharmaceuticals has the potential to revolutionize treatment options for various diseases. His innovative methods and collaborations highlight his commitment to advancing medical science.